StockData

Accuray vs LeMaitre Vascular

ARAY and LMAT side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ARAY and LMAT compare

LeMaitre Vascular is the larger company, worth 5.8 times as much as Accuray ($1.8B against $305M).

LeMaitre Vascular grew revenue faster over the last twelve months (11.8% versus −12.3% for Accuray).

LeMaitre Vascular keeps more of each dollar of sales as profit, with a net margin of 25.0% compared with −12.2% at Accuray.

LeMaitre Vascular pays a dividend yielding 1.2%; Accuray does not pay one.

LeMaitre Vascular scores higher on the StockData Score (22 against 2 for Accuray), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricARAYLMAT
Size and price
Market cap$305M$1.8B
Share price$2.55$77.01
Change, 1 year−94.3%−14.1%
Change, 5 years−98.8%57.9%
Beta (5Y)–−0.27
Employees809655
StockData Score
Total score222 (better)
Valuation score05 (better)
Growth score05 (better)
Performance score15 (better)
Health score13 (better)
Dividend score04 (better)
Valuation
P/E–27.0×
P/S0.8× (better)6.7×
P/B7.3×4.2× (better)
EV/EBITDA–15.8×
P/FCF–23.9×
PEG–0.69
FCF yield−4.2%4.2% (better)
Fair value–$97.56
Margin of safety–21.1%
Growth
Revenue growth (TTM)−12.3%11.8% (better)
Revenue growth, 5Y average0.28%14.0% (better)
Net income growth (TTM)–39.4%
EPS growth (TTM)–38.3%
EPS growth, 5Y average–19.4%
Profitability
Gross margin27.7%72.9% (better)
Operating margin−6.6%29.5% (better)
Net margin−12.2%25.0% (better)
FCF margin−3.2%28.1% (better)
Return on equity−80.1%16.8% (better)
Return on invested capital−13.0%137% (better)
Financial health
Debt / equity3.55–
Interest coverage−0.8×14.9× (better)
Current ratio1.5016.31 (better)
Altman Z-score−0.376.92 (better)
Piotroski F-score16 (better)
Dividends and buybacks
Dividend yield–1.2%
Payout ratio–31.2%
Years of dividend growth–14
Dividend growth, 5Y average–16.1%
Buyback yield−0.22%0.10% (better)
Shareholder yield−0.22%1.3% (better)
Ownership
Held by institutions59.9%100.0%
Held by insiders28.7%9.0%
Insider net buying, 12 months$134K (better)−$30.0M
Short interest, % of float6.6%8.0%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.